Table S1, shRNA Sequences; Table S2, antibodies for immunoblot; Table S3, antibodies for immunofluorescence; Table S4, correlations between CXCL5 expression and clinical characteristics in CRC patients; Table S5, univariate and multivariate analyses of CXCL5 expression in CRC patients; Table S6, pathological stages of patients in Fig. 2A&B; Supplementary methods. (DOC 178 kb
Table S1. Characteristics of the colorectal cancer patients analyzed in this study. Table S2. The pr...
Figure S1. Ingenuity Pathway Analysis (IPA) identifies enriched top pathway networks in CRC.Figure S...
Table S1. Sequences of the primers in this study. Table S2. Personal characteristic of patients part...
Increased expression of CXCL5 in CRC tissues and calibration curve. A: An immunoblot showing that CX...
X-tile analysis of survival data in CRC patients reveals a continuous distribution based on CXCL5 st...
Figure S1. Correlation of CYR61 expression of CRC tissues in IHC and clinicopathological parameters....
Figure S1. Prognostic value of EIF4A1, EIF4A2 and EIF4A3. Figure S2. A prognostic nomogram based on ...
Table S1. Sample details. Table S2. BMP5 primer sequences. Table S3. qPCR Primers used in this study...
Clinical characteristics of NSCLC patients. Table S2. DNA sequences of real-time PCR primers used fo...
Western blot analysis of protein level in paired colorectal carcinoma (CRC) and normal colon mucosae...
Table S1. Primers for genotyping of CXCR4 transgenic mice and ApcMin/+ mice. Table S2. Antibodies fo...
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Table S1. Target sequences of vshRNAs used in this study. Table S2. Primary antibodies for WB, IHC, ...
Supplementary Methods: Real-time (q)PCR. Table S1: Comparison of the effects of chemotherapeutic age...
Supplementary materials and methods, including Quantitative RT-PCR, Western blotting, Flow cytometry...
Table S1. Characteristics of the colorectal cancer patients analyzed in this study. Table S2. The pr...
Figure S1. Ingenuity Pathway Analysis (IPA) identifies enriched top pathway networks in CRC.Figure S...
Table S1. Sequences of the primers in this study. Table S2. Personal characteristic of patients part...
Increased expression of CXCL5 in CRC tissues and calibration curve. A: An immunoblot showing that CX...
X-tile analysis of survival data in CRC patients reveals a continuous distribution based on CXCL5 st...
Figure S1. Correlation of CYR61 expression of CRC tissues in IHC and clinicopathological parameters....
Figure S1. Prognostic value of EIF4A1, EIF4A2 and EIF4A3. Figure S2. A prognostic nomogram based on ...
Table S1. Sample details. Table S2. BMP5 primer sequences. Table S3. qPCR Primers used in this study...
Clinical characteristics of NSCLC patients. Table S2. DNA sequences of real-time PCR primers used fo...
Western blot analysis of protein level in paired colorectal carcinoma (CRC) and normal colon mucosae...
Table S1. Primers for genotyping of CXCR4 transgenic mice and ApcMin/+ mice. Table S2. Antibodies fo...
List of genes from the five different RT² Profiler™ PCR Array Human Systems used in this study, clas...
Table S1. Target sequences of vshRNAs used in this study. Table S2. Primary antibodies for WB, IHC, ...
Supplementary Methods: Real-time (q)PCR. Table S1: Comparison of the effects of chemotherapeutic age...
Supplementary materials and methods, including Quantitative RT-PCR, Western blotting, Flow cytometry...
Table S1. Characteristics of the colorectal cancer patients analyzed in this study. Table S2. The pr...
Figure S1. Ingenuity Pathway Analysis (IPA) identifies enriched top pathway networks in CRC.Figure S...
Table S1. Sequences of the primers in this study. Table S2. Personal characteristic of patients part...